162 related articles for article (PubMed ID: 33143292)
1. Functional Characterization of Colon-Cancer-Associated Variants in
Dobert JP; Cabron AS; Arnold P; Pavlenko E; Rose-John S; Zunke F
Biomedicines; 2020 Oct; 8(11):. PubMed ID: 33143292
[TBL] [Abstract][Full Text] [Related]
2. Functional Characterization of Colon Cancer-Associated Mutations in
Pavlenko E; Cabron AS; Arnold P; Dobert JP; Rose-John S; Zunke F
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31060243
[TBL] [Abstract][Full Text] [Related]
3. Distance dependent shedding of IL-6R.
Düsterhöft S; Bartels AK; Koudelka T; Lilienthal E; Schäfer M; Garbers C; Tholey A; Grötzinger J; Lorenzen I
Biochem Biophys Res Commun; 2020 May; 526(2):355-360. PubMed ID: 32222277
[TBL] [Abstract][Full Text] [Related]
4. Secreted Frizzled-related protein 3 (sFRP3)-mediated suppression of interleukin-6 receptor release by A disintegrin and metalloprotease 17 (ADAM17) is abrogated in the osteoarthritis-associated rare double variant of sFRP3.
Oldefest M; Düsterhöft S; Desel C; Thysen S; Fink C; Rabe B; Lories R; Grötzinger J; Lorenzen I
Biochem J; 2015 Jun; 468(3):507-18. PubMed ID: 25846075
[TBL] [Abstract][Full Text] [Related]
5. Short-term TNFα shedding is independent of cytoplasmic phosphorylation or furin cleavage of ADAM17.
Schwarz J; Broder C; Helmstetter A; Schmidt S; Yan I; Müller M; Schmidt-Arras D; Becker-Pauly C; Koch-Nolte F; Mittrücker HW; Rabe B; Rose-John S; Chalaris A
Biochim Biophys Acta; 2013 Dec; 1833(12):3355-3367. PubMed ID: 24135057
[TBL] [Abstract][Full Text] [Related]
6. Circulating Soluble IL-6R but Not ADAM17 Activation Drives Mononuclear Cell Migration in Tissue Inflammation.
Schumacher N; Schmidt S; Schwarz J; Dohr D; Lokau J; Scheller J; Garbers C; Chalaris A; Rose-John S; Rabe B
J Immunol; 2016 Nov; 197(9):3705-3715. PubMed ID: 27698010
[TBL] [Abstract][Full Text] [Related]
7. A Disintegrin and Metalloproteinase Domain 17 Regulates Colorectal Cancer Stem Cells and Chemosensitivity Via Notch1 Signaling.
Wang R; Ye X; Bhattacharya R; Boulbes DR; Fan F; Xia L; Ellis LM
Stem Cells Transl Med; 2016 Mar; 5(3):331-8. PubMed ID: 26744411
[TBL] [Abstract][Full Text] [Related]
8. The metalloprotease ADAM17 in inflammation and cancer.
Düsterhöft S; Lokau J; Garbers C
Pathol Res Pract; 2019 Jun; 215(6):152410. PubMed ID: 30992230
[TBL] [Abstract][Full Text] [Related]
9. The membrane-proximal domain of A Disintegrin and Metalloprotease 17 (ADAM17) is responsible for recognition of the interleukin-6 receptor and interleukin-1 receptor II.
Lorenzen I; Lokau J; Düsterhöft S; Trad A; Garbers C; Scheller J; Rose-John S; Grötzinger J
FEBS Lett; 2012 Apr; 586(8):1093-100. PubMed ID: 22575642
[TBL] [Abstract][Full Text] [Related]
10. ADAM17 Activity and IL-6 Trans-Signaling in Inflammation and Cancer.
Schumacher N; Rose-John S
Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31694340
[TBL] [Abstract][Full Text] [Related]
11. Enhancing Interleukin-6 and Interleukin-11 receptor cleavage.
Lokau J; Wandel M; Garbers C
Int J Biochem Cell Biol; 2017 Apr; 85():6-14. PubMed ID: 28143719
[TBL] [Abstract][Full Text] [Related]
12. Extracellular Juxtamembrane Segment of ADAM17 Interacts with Membranes and Is Essential for Its Shedding Activity.
Düsterhöft S; Michalek M; Kordowski F; Oldefest M; Sommer A; Röseler J; Reiss K; Grötzinger J; Lorenzen I
Biochemistry; 2015 Sep; 54(38):5791-801. PubMed ID: 26348730
[TBL] [Abstract][Full Text] [Related]
13. ADAM17 inhibition enhances platinum efficiency in ovarian cancer.
Hedemann N; Rogmans C; Sebens S; Wesch D; Reichert M; Schmidt-Arras D; Oberg HH; Pecks U; van Mackelenbergh M; Weimer J; Arnold N; Maass N; Bauerschlag DO
Oncotarget; 2018 Mar; 9(22):16043-16058. PubMed ID: 29662625
[TBL] [Abstract][Full Text] [Related]
14. Cleavage Site Localization Differentially Controls Interleukin-6 Receptor Proteolysis by ADAM10 and ADAM17.
Riethmueller S; Ehlers JC; Lokau J; Düsterhöft S; Knittler K; Dombrowsky G; Grötzinger J; Rabe B; Rose-John S; Garbers C
Sci Rep; 2016 May; 6():25550. PubMed ID: 27151651
[TBL] [Abstract][Full Text] [Related]
15. ADAM17: a molecular switch to control inflammation and tissue regeneration.
Scheller J; Chalaris A; Garbers C; Rose-John S
Trends Immunol; 2011 Aug; 32(8):380-7. PubMed ID: 21752713
[TBL] [Abstract][Full Text] [Related]
16. The shedding protease ADAM17: Physiology and pathophysiology.
Zunke F; Rose-John S
Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt B):2059-2070. PubMed ID: 28705384
[TBL] [Abstract][Full Text] [Related]
17. Status update on iRhom and ADAM17: It's still complicated.
Düsterhöft S; Babendreyer A; Giese AA; Flasshove C; Ludwig A
Biochim Biophys Acta Mol Cell Res; 2019 Oct; 1866(10):1567-1583. PubMed ID: 31330158
[TBL] [Abstract][Full Text] [Related]
18. Hormone-induced expression of tumor necrosis factor alpha-converting enzyme/A disintegrin and metalloprotease-17 impacts porcine cumulus cell oocyte complex expansion and meiotic maturation via ligand activation of the epidermal growth factor receptor.
Yamashita Y; Kawashima I; Yanai Y; Nishibori M; Richards JS; Shimada M
Endocrinology; 2007 Dec; 148(12):6164-75. PubMed ID: 17901238
[TBL] [Abstract][Full Text] [Related]
19. Multimerisation of A disintegrin and metalloprotease protein-17 (ADAM17) is mediated by its EGF-like domain.
Lorenzen I; Trad A; Grötzinger J
Biochem Biophys Res Commun; 2011 Nov; 415(2):330-6. PubMed ID: 22033402
[TBL] [Abstract][Full Text] [Related]
20. Proteomic identification of desmoglein 2 and activated leukocyte cell adhesion molecule as substrates of ADAM17 and ADAM10 by difference gel electrophoresis.
Bech-Serra JJ; Santiago-Josefat B; Esselens C; Saftig P; Baselga J; Arribas J; Canals F
Mol Cell Biol; 2006 Jul; 26(13):5086-95. PubMed ID: 16782893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
